» Articles » PMID: 36733765

The Epidemiology of Inflammatory Bowel Disease: Clues to Pathogenesis?

Overview
Journal Front Pediatr
Specialty Pediatrics
Date 2023 Feb 3
PMID 36733765
Authors
Affiliations
Soon will be listed here.
Abstract

Historically, inflammatory bowel disease (IBD) was most common in North America and Europe and more common with a north-south gradient. Over the past century, there has been a marked increase in IBD in general and in childhood IBD in particular and over the past 50 years IBD has spread into the developing world. The greatest risk factor of developing IBD is an affected family member. Concordance rates between dizygotic twins is ∼4% and ∼50% in monozygotic twins, and more than half of pairs are diagnosed within 2 years of each other. Nevertheless, most patients with IBD do not have an affected family member. More than 200 genes are associated with an increased risk for IBD, but most associations are weak with odds ratios between 1.2 and 2.0 suggesting the environment plays a role. IBD is more common in urban than rural regions and is associated with "good standards" of domestic hygiene during childhood. People who migrate from areas with a low incidence to areas with a high incidence of IBD have an increased risk of developing IBD and the younger they are when they migrate, the greater their risk of developing IBD. Moreover, people who migrate from regions with a high incidence to areas with a low incidence of IBD have a decreased risk of developing IBD. Together, these findings strongly suggest particular environmental exposures occurring early in life may trigger inflammatory bowel disease in genetically susceptible individuals. The key is figuring out what those exposures might be.

Citing Articles

Comparison of 1-Year Clinical Course in Patients With Newly Diagnosed Inflammatory Bowel Disease Between Vietnam and Korea: A Multinational, Multicenter Retrospective Cohort Study.

Dang L, Kim E, Kim K, Lee Y, Bui H, Nguyen C JGH Open. 2025; 9(2):e70106.

PMID: 39963126 PMC: 11831005. DOI: 10.1002/jgh3.70106.


Helminths in alternative therapeutics of inflammatory bowel disease.

Pandey H, Tang D, Wong S, Lal D Intest Res. 2025; 23(1):8-22.

PMID: 39916482 PMC: 11834367. DOI: 10.5217/ir.2023.00059.


Neutrophils: From Inflammatory Bowel Disease to Colitis-Associated Colorectal Cancer.

Chen T, Liu J, Hang R, Chen Q, Wang D J Inflamm Res. 2025; 18:925-947.

PMID: 39871958 PMC: 11770381. DOI: 10.2147/JIR.S497701.


Chronic Gastrointestinal Disorders and miRNA-Associated Disease: An Up-to-Date.

Giammona A, Galuzzi B, Imperia E, Gervasoni C, Remedia S, Restaneo L Int J Mol Sci. 2025; 26(1.

PMID: 39796266 PMC: 11720538. DOI: 10.3390/ijms26010413.


Designing for medication adherence in inflammatory bowel disease: multi-disciplinary approaches for self-administrable biotherapeutics.

Feig V, Zhang S, Patel A, Santos B, Kang Z, Wasan S EClinicalMedicine. 2025; 77:102850.

PMID: 39763512 PMC: 11701474. DOI: 10.1016/j.eclinm.2024.102850.


References
1.
Sanmarco L, Chao C, Wang Y, Kenison J, Li Z, Rone J . Identification of environmental factors that promote intestinal inflammation. Nature. 2022; 611(7937):801-809. PMC: 9898826. DOI: 10.1038/s41586-022-05308-6. View

2.
Halfvarson J, Ludvigsson J, Bresso F, Askling J, Sachs M, Olen O . Age determines the risk of familial inflammatory bowel disease-A nationwide study. Aliment Pharmacol Ther. 2022; 56(3):491-500. DOI: 10.1111/apt.16938. View

3.
Kaplan G, Ng S . Globalisation of inflammatory bowel disease: perspectives from the evolution of inflammatory bowel disease in the UK and China. Lancet Gastroenterol Hepatol. 2017; 1(4):307-316. DOI: 10.1016/S2468-1253(16)30077-2. View

4.
de Souza H, Fiocchi C . Immunopathogenesis of IBD: current state of the art. Nat Rev Gastroenterol Hepatol. 2015; 13(1):13-27. DOI: 10.1038/nrgastro.2015.186. View

5.
Sykora J, Pomahacova R, Kreslova M, Cvalinova D, Stych P, Schwarz J . Current global trends in the incidence of pediatric-onset inflammatory bowel disease. World J Gastroenterol. 2018; 24(25):2741-2763. PMC: 6034144. DOI: 10.3748/wjg.v24.i25.2741. View